✦ LIBER ✦

Maintenance therapy with gradual reduction of the interferon dose over one year improves histological response in patients with chronic hepatitis C with biochemical response: results of a randomized trial

✍ Scribed by Laurent Alric; Michel Duffaut; Janik Selves; Karine Sandre; Marius Mularczyck; Jacques Izopet; Herve Desmorat; Christophe Bureau; Nadia Chaouche; Bernard Dalbergue; Jean-Pierre Vinel

Book ID: 119526633
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 174 KB
Volume: 35
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(01)00110-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to higher doses of interferon a

Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: A randomized multicenter trial

✍ K L Lindsay; G L Davis; E R Schiff; H C Bodenheimer; L A Balart; J L Dienstag; R 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

JANICE ALBRECHT, 12 AND THE HEPATITIS INTERVENTIONAL THERAPY GROUP\* with continued therapy at that dose; however, a propor-To evaluate response rates to 3, 5, or 10 million units tion of patients who do not respond to 12 weeks of treat-(MU) of interferon alfa-2b, given thrice weekly, and to ment wi

Iron reduction and sustained response to

Iron reduction and sustained response to interferon-α therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study

✍ Silvia Fargion; Anna Ludovica Fracanzani; Angelo Rossini; Mauro Borzio; Oliviero 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 56 KB

Time course of histological changes in p

Time course of histological changes in patients with a sustained biochemical and virological response to interferon-α therapy for chronic hepatitis C virus infection

✍ Akihito Tsubota; Hiromitsu Kumada; Kazuaki Chayama; Yasuji Arase; Satoshi Saitoh 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 895 KB

A pilot randomized, controlled trial of

A pilot randomized, controlled trial of the effect of iron depletion on long-term response to α-interferon in patients with chronic hepatitis C

✍ Tse-Ling Fong; Steven H. Han; Naoky C-S. Tsai; Timothy R. Morgan; Masashi Mizoka 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Randomized trial of high-dose interferon

Randomized trial of high-dose interferon-α-2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy

✍ Nami Mori; Michio Imamura; Yoshiiku Kawakami; Hiromi Saneto; Tomokazu Kawaoka; S 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB 👁 1 views

## Abstract The aim of this study was to compare the efficacy of high‐dose interferon (IFN)‐α‐2b with standard dose of IFN‐α‐2b in combination with ribavirin (RBV) for patients with chronic hepatitis C virus (HCV) infection, and to investigate the predictive factors associated with virological resp

Lymphoblastoid interferon alfa-n1 improv

Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial

✍ Geoffrey C. Farrell; Bruce R. Bacon; Robert D. Goldin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

The aim of this study was to compare the short-term and long-term efficacy and safety of lymphoblastoid interferon with a recombinant interferon alfa (IFN-␣) in a 24-week treatment course for chronic hepatitis C. One thousand seventy-one patients with chronic hepatitis C were randomized to receive l